Montalbán, X. ., Gold, R. ., Thompson, A. ., Otero-Romero, S. ., Amato, M. ., Chandraratna, D. ., … Zipp, F. . (2018). ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.13536 (Original work published 2018)

Fernández, O. ., Delvecchio, M. ., Edan, G. ., Fredrikson, S. ., Giovannoni, G. ., Hartung, H. ., … Comi, G. . (2018). Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management. European Journal of Neurology. https://doi.org/10.1111/ene.13581 (Original work published 2018)

Chitnis, T. ., González, C. ., Healy, B. ., Saxena, S. ., Rosso, M. ., Barro, C. ., … Kuhle, J. . (2018). Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology, 5(12), 1478-1491. https://doi.org/10.1002/acn3.638

Hauser, S. ., Bar-Or, A. ., Cohen, J. ., Comi, G. ., Correale, J. ., Coyle, P. ., … Trial, G. A. I. and A. , II. (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine, 383(6), 546-557. https://doi.org/10.1056/NEJMoa1917246 (Original work published 2020)